<DOC>
	<DOCNO>NCT00005082</DOCNO>
	<brief_summary>RATIONALE : New image procedure magnetic resonance imaging may improve ability detect extent newly diagnose cancer . PURPOSE : Diagnostic study magnetic resonance image determine extent cancer patient newly diagnose glioma .</brief_summary>
	<brief_title>Magnetic Resonance Imaging Determining Extent Cancer Patients With Newly Diagnosed Glioma</brief_title>
	<detailed_description>OBJECTIVES : I . Determine whether proton magnetic resonance spectroscopic imaging ( 1H-MRSI ) diffusion magnetic resonance imaging ( DI ) measure glioma cell burden correlate histopathologically measure cell count glioma patient schedule undergo surgical resection . II . Determine whether 1H-MRSI DI measure glioma cell burden invariant short term ( 1 week ) steroid dose increase patient . OUTLINE : Part I : Patients schedule surgical resection brain tumor undergo conventional magnetic resonance imaging ( MRI ) , proton magnetic resonance spectroscopic imaging ( 1H-MRSI ) , diffusion magnetic resonance imaging ( DI ) within 1 week resection . Patients undergo conventional MRI within 72 hour completion surgical resection . Image characteristic resect tissue correlate histopathological measure . Part II : Patients clinical indication increase dexamethasone dose treat part II study . Patients stratify status steroid treatment ( steroid naive v prior steroid management ) . Patients undergo conventional MRI , 1H-MRSI , DI within 2 day within 4-7 day increase dexamethasone dose . Image characteristic film take increase dexamethasone dose compare . PROJECTED ACCRUAL : A total 75 patient accrued part I study total 40 patient ( 20 per stratum ) accrue part II study within 4 year .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Part I : Presurgical : presumptive diagnosis intracranial glioma schedule undergo first surgical resection OR stereotactic biopsy Postsurgical : Histologically prove intracranial glioma schedule undergo surgical debulking Evaluable preoperative proton magnetic resonance spectroscopic imaging ( 1HMRSI ) diffusion magnetic resonance imaging ( DI ) scan complete within 1 week prior surgery Postoperative MRI , 1HMRSI , DI scan complete within 3 day surgery Part II : Presurgical : presumptive diagnosis intracranial glioma Postsurgical : Histologically prove intracranial glioma No surgery prior completion exit scan Clinical indication increase steroid dose Planned steroid change must 0 16 mg/day twofold increase Evaluable 1HMRSI DI scan No prior treatment protocol Parts I II : No contraindication magnetic resonance imaging ( MRI ) ( metallic implant , shrapnel fragment , claustrophobia , allergy MRI contrast ) PATIENT CHARACTERISTICS : Age : Parts I II : Over 18 Performance status : Parts I II : Not specify Life expectancy : Parts I II : Not specify Hematopoietic : Parts I II : Not specify Hepatic : Parts I II : Not specify Renal : Parts I II : Not specify PRIOR CONCURRENT THERAPY : Biologic therapy : Parts I II : Not specify Chemotherapy : Parts I II : Not specify Endocrine therapy : Part I : Not specify Part II : Steroid naive prior steroid management allow Radiotherapy : Parts I II : See Disease Characteristics Surgery : Part I : See Disease Characteristics No information 2 surgery one patient Part II : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>adult medulloblastoma</keyword>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult myxopapillary ependymoma</keyword>
	<keyword>adult anaplastic ependymoma</keyword>
	<keyword>adult anaplastic oligodendroglioma</keyword>
	<keyword>adult mixed glioma</keyword>
	<keyword>adult pilocytic astrocytoma</keyword>
	<keyword>adult subependymoma</keyword>
	<keyword>adult ependymoblastoma</keyword>
	<keyword>adult oligodendroglioma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
</DOC>